|
QSER1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.365400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.193600E-01 |
| Normal-vs-Stage2 |
3.959200E-01 |
| Normal-vs-Stage3 |
2.579000E-01 |
| Normal-vs-Stage4 |
9.371600E-01 |
| Stage1-vs-Stage2 |
2.303200E-01 |
| Stage1-vs-Stage3 |
1.308040E-01 |
| Stage1-vs-Stage4 |
9.096400E-01 |
| Stage2-vs-Stage3 |
9.294600E-01 |
| Stage2-vs-Stage4 |
5.350800E-01 |
| Stage3-vs-Stage4 |
4.642200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.769600E-01 |
| Normal-vs-AfricanAmerican |
8.158400E-01 |
| Normal-vs-Asian |
5.530400E-01 |
| Caucasian-vs-AfricanAmerican |
9.343200E-01 |
| Caucasian-vs-Asian |
7.028600E-01 |
| AfricanAmerican-vs-Asian |
6.852600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.164600E-01 |
| Normal-vs-Female |
6.475300E-03 |
| Male-vs-Female |
8.550800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.632400E-01 |
| Normal-vs-Extreme_Weight |
2.604800E-01 |
| Normal-vs-Obese |
1.097610E-01 |
| Normal-vs-Extreme_Obese |
5.044200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.178400E-01 |
| Normal_Weight-vs-Obese |
1.022650E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.745600E-01 |
| Extreme_Weight-vs-Obese |
1.966380E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.180200E-01 |
| Obese-vs-Extreme_Obese |
2.150400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.203600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.456300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.261600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.329900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.857390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.884100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.427770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.102600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.293600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.146200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.422600E-01 |
| Normal-VS-Type2 PRCC |
7.626100E-02 |
| Normal-VS-KIRP CIMP |
4.464200E-02 |
| Normal-VS-Unclassified PRCC |
1.613850E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.702400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.574100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.594200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.144000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.398300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.017190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.432200E-02 |
| Normal-vs-N1 |
3.331800E-02 |
| Normal-vs-N2 |
6.648000E-01 |
| N0-vs-N1 |
4.703200E-03 |
| N0-vs-N2 |
7.157600E-01 |
| N1-vs-N2 |
2.873000E-01 |
|
|
